107 related articles for article (PubMed ID: 9817540)
1. Multiple sclerosis clinical trials: old and new challenges.
Noseworthy JH
Semin Neurol; 1998; 18(3):377-88. PubMed ID: 9817540
[TBL] [Abstract][Full Text] [Related]
2. Early treatment trials with interferon beta in multiple sclerosis.
Panitch HS
Mult Scler; 1995; 1 Suppl 1():S17-21. PubMed ID: 9345392
[TBL] [Abstract][Full Text] [Related]
3. Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.
Goodkin DE
West J Med; 1994 Sep; 161(3):292-8. PubMed ID: 7975569
[TBL] [Abstract][Full Text] [Related]
4. Management of worsening multiple sclerosis with mitoxantrone: a review.
Fox EJ
Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
[TBL] [Abstract][Full Text] [Related]
5. Evolving therapies for multiple sclerosis.
Korniychuk E; Dempster JM; O'Connor E; Alexander JS; Kelley RE; Kenner M; Menon U; Misra V; Hoque R; Gonzalez-Toledo E; Schwendimann RN; Smith S; Minagar A
Int Rev Neurobiol; 2007; 79():571-88. PubMed ID: 17531859
[TBL] [Abstract][Full Text] [Related]
6. Disability as an outcome in MS clinical trials.
Ebers GC; Heigenhauser L; Daumer M; Lederer C; Noseworthy JH
Neurology; 2008 Aug; 71(9):624-31. PubMed ID: 18480462
[TBL] [Abstract][Full Text] [Related]
7. Reconsidering clinical outcomes in Multiple Sclerosis: relapses, impairment, disability and beyond.
D'Souza M; Kappos L; Czaplinski A
J Neurol Sci; 2008 Nov; 274(1-2):76-9. PubMed ID: 18817932
[TBL] [Abstract][Full Text] [Related]
8. A composite score to predict short-term disease activity in patients with relapsing-remitting MS.
Sormani MP; Rovaris M; Comi G; Filippi M
Neurology; 2007 Sep; 69(12):1230-5. PubMed ID: 17875911
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
Miller DH; Albert PS; Barkhof F; Francis G; Frank JA; Hodgkinson S; Lublin FD; Paty DW; Reingold SC; Simon J
Ann Neurol; 1996 Jan; 39(1):6-16. PubMed ID: 8572668
[TBL] [Abstract][Full Text] [Related]
10. Methodological problems in evaluating efficacy of a treatment in multiple sclerosis.
Waubant E; Goodkin D
Pathol Biol (Paris); 2000 Mar; 48(2):104-13. PubMed ID: 10815286
[TBL] [Abstract][Full Text] [Related]
11. Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double-blind, placebo controlled trial.
Lappin MS; Lawrie FW; Richards TL; Kramer ED
Altern Ther Health Med; 2003; 9(4):38-48. PubMed ID: 12868251
[TBL] [Abstract][Full Text] [Related]
12. [Long-term effects of glatiramer acetate in multiple sclerosis].
Brochet B
Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.
Sandberg-Wollheim M; Hommes OR; Hughes RA; Paty DW; Abdul-Ahad AK
Mult Scler; 1995; 1 Suppl 1():S48-50. PubMed ID: 9345399
[TBL] [Abstract][Full Text] [Related]
14. Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study.
Comi G; Barkhof F; Durelli L; Edan G; Fernandez O; Filippi M; Hartung HP; Hommes OR; Seeldrayers P; Soelberg-Sorensen P
Mult Scler; 1995; 1 Suppl 1():S24-7. PubMed ID: 9345394
[TBL] [Abstract][Full Text] [Related]
15. Fumarates for the treatment of multiple sclerosis: potential mechanisms of action and clinical studies.
Linker RA; Lee DH; Stangel M; Gold R
Expert Rev Neurother; 2008 Nov; 8(11):1683-90. PubMed ID: 18986239
[TBL] [Abstract][Full Text] [Related]
16. Methodology of clinical trials in multiple sclerosis.
Mitsikostas DD
Neurol Sci; 2006 Sep; 27 Suppl 5():S362-4. PubMed ID: 16998721
[TBL] [Abstract][Full Text] [Related]
17. Intravenous polyclonal human immunoglobulins in multiple sclerosis.
Soelberg Sorensen P
Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269
[TBL] [Abstract][Full Text] [Related]
18. Early treatment.
Comi G
Neurol Sci; 2006 Mar; 27 Suppl 1():S8-12. PubMed ID: 16708191
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
Stuart WH
Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719
[TBL] [Abstract][Full Text] [Related]
20. [Is immunosuppression a future therapeutic strategy for multiple sclerosis?].
Edan G; Coustans M
Pathol Biol (Paris); 2000 Mar; 48(2):114-20. PubMed ID: 10815287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
